Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-09-26
1991-07-23
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514913, A61K 4376
Patent
active
050344064
ABSTRACT:
A method of reducing or maintaining intraocular pressure in a mammalian eye, e.g., affected with glaucoma, is disclosed. This method comprises administering directly to the mammalian eye an effective amount of one or more 2-cycloalkylamino oxazolines, salts thereof, bases thereof and mixtures thereof.
REFERENCES:
patent: 3598833 (1971-08-01), Hiltmann et al.
patent: 3676798 (1972-07-01), Guilk et al.
patent: 4861760 (1989-08-01), Mazuel et al.
Review: A Synopsis of Recent Developments in Antiglaucoma Drugs, Marsha A. McLaughlin and George C. Y. Chiou.
Editorial: Intraocular Pressure and Glaucoma, Alfred Sommer.
German Article: Stereochemische Untersuchungen uber Arzneimittel. 4 Mitt. (*) Konformation and antihypertensive Wirksamkeit von 2-(2,6-Dialkycyclohexyl)-amino-2-oxazolinen (**) Hiltmann, Kurz, Wollweber and Stoepel.
Allergan Inc.
Fay Zohreh A.
Friedman Stanley J.
Peterson Gordon L.
Uxa, Jr. Frank J.
LandOfFree
Method for reducing or maintaining intraocular pressure does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for reducing or maintaining intraocular pressure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for reducing or maintaining intraocular pressure will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-432549